Mimedx (MDXG) Revenue (2011 - 2026)

Mimedx has disclosed Revenue across 16 years of filings, most recently posting $59.0 million for Q1 2026.

• Revenue for Q1 2026 came in at $59.0 million, down 33.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $389.4 million (up 10.51% YoY), and the FY2025 annual result was $418.6 million, up 19.99% from the prior year.
• Revenue came in at $59.0 million for Q1 2026 at Mimedx, down from $118.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $118.1 million in Q4 2025 to a low of $58.9 million in Q1 2022.
• The 5-year median for Revenue is $84.1 million (2024), against an average of $83.3 million.
• Across the five-year window, Revenue soared 46.37% in 2022 and sank 33.12% in 2026, its largest moves.
• Mimedx's Revenue stood at $74.4 million in 2022, then rose by 16.75% to $86.8 million in 2023, then gained by 7.0% to $92.9 million in 2024, then advanced by 27.11% to $118.1 million in 2025, then plunged by 50.05% to $59.0 million in 2026.
• The last three Revenue figures came in at $59.0 million (Q1 2026), $118.1 million (Q4 2025), and $113.7 million (Q3 2025), per Business Quant data.